Stivarga 40 MG tablet 21S
Ended Awarded
- Contract number
- SPE2DX25F6AHJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $30,615
Award facts
- Contract value 100% obligated
- $30,614.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $30.6K on September 26, 2025, for the supply of Stivarga 40 mg tablets (21-count packages). The contract, which carries an ultimate completion date of September 29, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain division and represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency. This award does not utilize a small business set-aside designation, allowing the contractor to compete on an unrestricted basis despite its woman-owned small business status.
Stivarga (regorafenib) is an oral multikinase inhibitor used in oncology treatments, and its procurement through the federal supply system supports pharmaceutical inventory requirements for Department of Defense healthcare facilities. DMS Pharmaceutical Group maintains a robust portfolio of federal pharmaceutical supply contracts, leveraging its established position as a critical supplier within the Defense Logistics Agency's pharmaceutical distribution network. The contractor's primary IDC with the Defense Logistics Agency, valued at $499.9M through November 2026, enables the issuance of firm fixed-price delivery orders across a comprehensive range of branded and generic medications, biologics, and medical consumables serving military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6AHJ?
SPE2DX25F6AHJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 26, 2025.
How much is contract SPE2DX25F6AHJ worth?
The government has obligated $30,615 on SPE2DX25F6AHJ.
Is contract SPE2DX25F6AHJ an order under another contract?
Yes. SPE2DX25F6AHJ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AHJ competed?
The extent of competition for SPE2DX25F6AHJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award